F E Young1, S L Nightingale. Show Affiliations » 1. Food and Drug Administration, Rockville, MD 20857.
Abstract
Mesh： See more » Clinical ProtocolsCytomegalovirus/immunologyCytomegalovirus Infections/therapyDrug Combinations/administration & dosageDrug Combinations/therapeutic useDrug Therapy, CombinationGlucuronates/administration & dosageGlucuronates/therapeutic useHumansImmune Sera/administration & dosageImmunoglobulinsImmunoglobulins, IntravenousKidney TransplantationLeucovorin/administration & dosagePneumonia, Pneumocystis/drug therapyQuinazolines/administration & dosageQuinazolines/therapeutic useTrimetrexate/analogs & derivativesUnited StatesUnited States Food and Drug Administration
Substances： See more » Drug CombinationsGlucuronatesImmune SeraImmunoglobulinsImmunoglobulins, IntravenousQuinazolinescytomegalovirus-specific hyperimmune globulintrimetrexate glucuronateLeucovorinTrimetrexate
Year: 1988 PMID： 2838651
Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272